Copyright
©The Author(s) 2019.
World J Gastroenterol. Jan 21, 2019; 25(3): 388-397
Published online Jan 21, 2019. doi: 10.3748/wjg.v25.i3.388
Published online Jan 21, 2019. doi: 10.3748/wjg.v25.i3.388
Figure 1 Incidence of somatoform symptoms in patients with gastroesophageal reflux disease.
Group A: patients with indication for surgery, willing to undergo surgery. The percentage of SSI ≥ 17 was 22%; Group B: Patients with GERD and indication for surgery, who has refused antireflux surgery and have continued protonpump inhibitors therapy. The percentage of SSI ≥ 17 was 20%. GERD: Gastroesophageal reflux disease; SSI: Somatoform Symptom Index.
- Citation: Fuchs HF, Babic B, Fuchs KH, Breithaupt W, Varga G, Musial F. Do patients with gastroesophageal reflux disease and somatoform tendencies benefit from antireflux surgery? World J Gastroenterol 2019; 25(3): 388-397
- URL: https://www.wjgnet.com/1007-9327/full/v25/i3/388.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i3.388